Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Lilly identifies new O-GlcNAcase inhibitors

Feb. 20, 2020

resTORbio presents interim phase Ib/IIa data for RTB-101 in PD along with corporate update

Feb. 20, 2020

Zelira's phase Ib/IIa study of ZLT-101 in insomnia meets primary endpoints

Feb. 19, 2020

Novel microglia-specific reporter mouse model based on the TMEM119 microglia marker

Feb. 19, 2020

Bipolar-like behavior key factor found in iPSCs and mice

Feb. 19, 2020

Nanogold improves MS symptoms

Feb. 19, 2020

Thanks for the memories, myelin

Feb. 19, 2020

Progranulin gene therapy has therapeutic effects in knockout model

Feb. 18, 2020

Neuropore receives a grant to developTLR2 agonist for ALS

Feb. 18, 2020

Strengthening lysosomes could head Parkinson's off at the pass

Feb. 18, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...